Covered recipient · General Payments record
GLENDA DARLENE BAGBY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,760.63
- Reported across 119 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $250.39 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $161.91 | 13 |
| Lilly USA, LLC | $30.12 | 2 |
| Xeris Pharmaceuticals, Inc. | $15.24 | 1 |
| GlaxoSmithKline, LLC. | $14.50 | 1 |
| Acerta Pharma LLC | $14.39 | 1 |
| PFIZER INC. | $14.23 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $11.35 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106468236 | CMS |
| ABBVIE INC. | $4.24 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106468238 | CMS |
| ABBVIE INC. | $16.03 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106468240 | CMS |
| ABBVIE INC. | $16.89 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106468242 | CMS |
| ABBVIE INC. | $12.26 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106468244 | CMS |
| ABBVIE INC. | $17.83 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106468246 | CMS |
| ABBVIE INC. | $11.51 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106468248 | CMS |
| ABBVIE INC. | $1.80 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106468250 | CMS |
| ABBVIE INC. | $17.83 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106468252 | CMS |
| ABBVIE INC. | $18.18 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106468254 | CMS |
| ABBVIE INC. | $2.46 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106468256 | CMS |
| ABBVIE INC. | $19.50 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106468258 | CMS |
| ABBVIE INC. | $12.03 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106468260 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.39 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104565530 | CMS |
| GlaxoSmithKline, LLC. | $14.50 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116536178 | CMS |
| Lilly USA, LLC | $14.91 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135672138 | CMS |
| Lilly USA, LLC | $15.21 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135639542 | CMS |
| PFIZER INC. | $14.23 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132111003 | CMS |
| Xeris Pharmaceuticals, Inc. | $15.24 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144626559 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.